Mumbai-based Lupin has received approval from the U.S. FDA to market Pitavastatin tablets, used for lowering cholesterol.
Lupin's Nikita Pitavastatin tablets are a generic version of Kowa Company’s Livalo tablets. According to Lupin, As per IMS MAT June 2017 data, Livalo tablets had sales of $272 million in the U.S.
Nikita is ideal for patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotien B, triglycerides and to increase high-density lipoprotein cholesterol, says Lupin.
Read the ET coverage
